IpsenOvjeren akaunt

@IpsenGroup

We are driven by a passion for improvement and innovation in solutions for those living with debilitating conditions. Terms of use:

Vrijeme pridruživanja: ožujak 2011.

Medijski sadržaj

  1. Sharing learnings from a real-world case study, Pascale Cavillon, Patient Centricity Director & Jean-Charles Dhuin, Head of GMA Clinical Operations discuss why a patient-centric approach is key to successful, non-interventional studies at the 12th Annual

  2. 4. velj

    What's it like to be diagnosed with a rare cancer? Follow us on Instagram and find out on our Stories, where we're sharing Ronny's journey for World Cancer Day:

  3. 2. velj

    Since the development of our NET Symptom Index, clinicians and patient advocacy groups have approached us to integrate it in their studies, helping us further collaborate with the community. Read more:

  4. 21. sij

    Problems with paywalls? Not here. We’re proud to announce that we honored our commitment to accessibility and transparency with our 100% record for open-access publication in 2019.

  5. 15. sij

    Head of Global Business Development Oncology, Elena Ritsou, discusses how joining other leaders at the 38th J.P. Morgan Healthcare Conference helps fuel Ipsen's external innovation strategy.

  6. 14. sij

    Here's what Eugenia Litz, Vice President Investor Relations at Ipsen, has to say about the importance of networking with industry peers at the 38th J.P. Morgan Healthcare Conference.

  7. 13. sij

    Chief Executive Officer, Aymeric Le Chatelier, speaks about Ipsen's growth and trajectory for continued success on the first day of the 38th J.P. Morgan Healthcare Conference.

  8. 8. sij

    Over 75% of children with cerebral palsy experience spasticity, a muscle control disorder interfering with movement and speech. Spasticity can be particularly difficult for children, impacting the ability to perform daily tasks.

  9. 7. sij

    It's estimated that 12 million people worldwide are living with spasticity, a condition usually caused by damage to nerves in the brain or spinal cord that are responsible for our control over voluntary movement. Learn more:

  10. 6. sij

    Ipsen is committed to improving the lives of patients with spasticity and movement disorders. Read our latest announcement here:

  11. 1. sij

    Happy new year from the entire Ipsen family! 🎊 We're excited for another year of growth and innovation, and are more dedicated than ever to delivering improved patient outcomes.

  12. 20. pro 2019.

    Our commitment to patient centricity is exemplified by our colleagues around the world. For Ana, working at Ipsen means she can have a real impact on patients' lives.

  13. 17. pro 2019.

    in educating people about . Marin lives with fibrodsyplasia ossificans progressiva, or , and you can listen to her story here.

  14. 9. pro 2019.

    Today marks World Anti-Corruption Day, and so we are re-affirming our staunch commitment to the UN Global Compact Programme, and stand . Read more from our interview with Dominique Laymand:

  15. 9. pro 2019.

    Make 2020 your year, and join us for the next chapter of our growth story. We have exciting opportunities at our locations worldwide:

  16. 5. pro 2019.

    At Ipsen, listening to and learning from patient feedback is central to how we improve patient care. Many people living with NETs face daily challenges, so reliable information and support is key. See more from our patient survey:

  17. 28. stu 2019.

    Chief Patient Affairs Officer, Isabelle Bocher-Pianka, is the catalyst interviewee in the latest issue of , and speaks about why working with patients is more important to the pharma industry than ever before. Read the interview in full here:

  18. 27. stu 2019.

    Prostate cancer is the second most common cancer in men, affecting more than 5.6 million men worldwide. Early detection is crucial for improving survival.

  19. 25. stu 2019.

    Let's make sure people with don't get left behind. In conjunction with , in the fight for better patient outcomes.

  20. 21. stu 2019.

    Ipsen is quickly becoming a leading global player in Oncology, Neuroscience and Rare Diseases. Hear more about our next cycle of growth from EVP and Chief Commercial Officer Harout Semerjian.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·